[22 March 2013]
Products Affected - Description
Phentolamine Mesylate Injection
Reason for the Shortage
- Bedford had phentolamine injection on shortage due to manufacturing delays.
- In cooperation with FDA, Sandoz Canada was providing phentolamine mesylate to the US market but this is no longer needed since Bedford has supply.
Available Products
Phentolamine mesylate for injection, Bedford
5 mg lyophilized vial (NDC 55390-0113-01)
Estimated Resupply Dates
Bedford has phentolamine mesylate 5 mg vials readily available.
Related Shortages
Updated
March 22, 2013; February 20, 2013; December 20, 2012; November 15, 2012; September 25, 2012; August 15, 2012; August 7, 2012; June 21, 2012; April 24, 2012; February 15, 2012; January 20, 2012; December 6, 2011; November 23, 2011; October 6, 2011; August 3, 2011; July 12, 2011; July 1, 2011; June 23, 2011; May 5, 2011, University of Utah, Drug Information Service. Copyright 2013, University of Utah, Drug Information Service.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins